SAC Capital is reportedly being sued by Wyeth investors over insider trading, just one month...
SAC Capital is reportedly being sued by Wyeth investors over insider trading, just one month after it settled with federal regulators for over $600M under similar allegations. SAC came under fire last year as former fund manager Mathew Martoma was charged with illegally obtaining results from an Alzheimer's drug trial being conducted by Wyeth (now part of Pfizer (PFE)) and Elan (ELN), then trading on the information before the data was made public.
From other sites
Video at CNBC.com (Thu, 12:00PM)
Video at CNBC.com (Wed, 12:48PM)
Video at CNBC.com (Jul 6, 2016)
Video at CNBC.com (Jul 1, 2016)
Video at CNBC.com (Jun 20, 2016)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs